The use of artificial intelligence in clinical trials is being explored for its potential to increase speed, volume, and diversity. This development is part of a broader trend of adopting ai in the healthcare and pharmaceutical industries, which may lead to significant changes and growth in the life science market. The impact of ai on clinical trials and the pharmaceutical industry is being discussed by various industry leaders and organizations.